Filing Details

Accession Number:
0001179110-11-008983
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-31 19:31:32
Reporting Period:
2011-05-26
Filing Date:
2011-05-31
Accepted Time:
2011-05-31 19:31:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1316175 Anthera Pharmaceuticals Inc ANTH Pharmaceutical Preparations (2834) 201852016
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1098349 E Alan Salzman 1001 Bayhill Drive, Suite 300
San Bruno CA 94066
No No Yes No
1114993 Vantagepoint Venture Partners Iv Lp 1001 Bayhill Drive, Suite 300
San Bruno CA 94066
No No Yes No
1129585 Vantagepoint Venture Partners Iv Q Lp 1001 Bayhill Drive, Suite 300
San Bruno CA 94066
No No Yes No
1256847 Vantagepoint Venture Associates Iv Llc 1001 Bayhill Drive, Suite 300
San Bruno CA 94066
No No Yes No
1267585 Vantagepoint Venture Partners Iv Principals Fund Lp 1001 Bayhill Drive, Suite 300
San Bruno CA 94066
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-05-26 4,349 $8.60 4,840,823 No 4 S Direct
Common Stock Disposition 2011-05-26 435 $8.60 484,614 No 4 S Direct
Common Stock Disposition 2011-05-26 16 $8.60 17,628 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The General Partner of VantagePoint Venture Partners IV (Q), L.P., VantagePoint Venture Partners IV, L.P., and VantagePoint Venture Partners IV Principals Fund, L.P. is VantagePoint Venture Associates IV, L.L.C. Alan E. Salzman is a managing member of the General Partner and may be deemed to have voting and investment power with respect to the shares or warrants held by these entities. Mr. Salzman disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The address for these entities and Mr. Salzman is 1001 Bayhill Drive, Suite 300, San Bruno, CA 94066
  2. By: VantagePoint Venture Partners IV (Q), L.P.
  3. By: VantagePoint Venture Partners IV, L.P.
  4. By: VantagePoint Venture Partners IV Principals Fund, L.P.
  5. The Reporting Persons undertake to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Shares were sold at prices between $8.60 and $8.63 per share (rounded to the nearest $.01)